Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 52
16
Diseases
76
Unique genes
0.140
Avg. similarity score
Microphthalmia
Most-connected disease (12 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Microphthalmia
Colobomatous microphthalmia
Microphthalmos
Nanophthalmos
Anophthalmia/microphthalmia-esophageal atresia syndrome
Congenital cystic eyeball
Anophthalmia
Colobomatous optic disc macular atrophy chorioretinopathy syndrome
Focal dermal hypoplasia
isolated microphthalmia 6
Klippel-feil syndrome
Microphthalmia with retinitis pigmentosa and ocular anomalies
colobomatous microphthalmia-rhizomelic dysplasia syndrome
Klippel-Feil anomaly-myopathy-facial dysmorphism syndrome
X-linked colobomatous microphthalmia, microcephaly, intellectual disability, short stature syndrome
nanophthalmos 4
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Microphthalmia | 12 | 12 | 38 |
| Colobomatous microphthalmia | 10 | 10 | 15 |
| Microphthalmos | 9 | 9 | 36 |
| Nanophthalmos | 8 | 8 | 12 |
| Anophthalmia/microphthalmia-esophageal atresia syndrome | 6 | 6 | 25 |
| Congenital cystic eyeball | 6 | 6 | 6 |
| Anophthalmia | 4 | 4 | 14 |
| Colobomatous optic disc macular atrophy chorioretinopathy syndrome | 4 | 4 | 2 |
| Focal dermal hypoplasia | 4 | 4 | 1 |
| isolated microphthalmia 6 | 4 | 4 | 1 |
| Klippel-feil syndrome | 3 | 3 | 7 |
| Microphthalmia with retinitis pigmentosa and ocular anomalies | 3 | 3 | 2 |
| colobomatous microphthalmia-rhizomelic dysplasia syndrome | 2 | 2 | 1 |
| Klippel-Feil anomaly-myopathy-facial dysmorphism syndrome | 1 | 1 | 1 |
| X-linked colobomatous microphthalmia, microcephaly, intellectual disability, short stature syndrome | 1 | 1 | 1 |
| nanophthalmos 4 | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| RAX | 7 / 16 | Anophthalmia, Anophthalmia/microphthalmia-esophageal atresia syndrome, Colobomatous microphthalmia, Congenital cystic eyeball and 3 more |
| OTX2 | 6 / 16 | Anophthalmia, Anophthalmia/microphthalmia-esophageal atresia syndrome, Colobomatous microphthalmia, Microphthalmia and 2 more |
| SOX2 | 6 / 16 | Anophthalmia, Anophthalmia/microphthalmia-esophageal atresia syndrome, Colobomatous microphthalmia, Microphthalmia and 2 more |
| VSX2 | 6 / 16 | Anophthalmia, Anophthalmia/microphthalmia-esophageal atresia syndrome, Colobomatous microphthalmia, Congenital cystic eyeball and 2 more |
| ALDH1A3 | 5 / 16 | Colobomatous microphthalmia, Congenital cystic eyeball, Microphthalmia, Microphthalmos and 1 more |
| GDF3 | 5 / 16 | Colobomatous microphthalmia, Congenital cystic eyeball, Klippel-feil syndrome, Microphthalmia and 1 more |
| GDF6 | 5 / 16 | Colobomatous microphthalmia, Congenital cystic eyeball, Klippel-feil syndrome, Microphthalmia and 1 more |
| PORCN | 5 / 16 | Anophthalmia/microphthalmia-esophageal atresia syndrome, Colobomatous microphthalmia, Focal dermal hypoplasia, Microphthalmia and 1 more |
| PRSS56 | 5 / 16 | Congenital cystic eyeball, isolated microphthalmia 6, Microphthalmia, Microphthalmos and 1 more |
| SIX6 | 5 / 16 | Anophthalmia/microphthalmia-esophageal atresia syndrome, Colobomatous microphthalmia, Colobomatous optic disc macular atrophy chorioretinopathy syndrome, Microphthalmia and 1 more |
| STRA6 | 5 / 16 | Anophthalmia, Anophthalmia/microphthalmia-esophageal atresia syndrome, Colobomatous microphthalmia, Microphthalmia and 1 more |
| MFRP | 4 / 16 | Microphthalmia, Microphthalmia with retinitis pigmentosa and ocular anomalies, Microphthalmos, Nanophthalmos |
| PAX6 | 4 / 16 | Anophthalmia, Anophthalmia/microphthalmia-esophageal atresia syndrome, Microphthalmia, Microphthalmos |
| RBP4 | 4 / 16 | Anophthalmia, Colobomatous microphthalmia, Microphthalmia, Microphthalmos |
| ABCB6 | 3 / 16 | Colobomatous microphthalmia, Microphthalmia, Microphthalmos |
| C14ORF39 | 3 / 16 | Anophthalmia/microphthalmia-esophageal atresia syndrome, Colobomatous optic disc macular atrophy chorioretinopathy syndrome, Microphthalmia |
| C1QTNF5 | 3 / 16 | Microphthalmia, Microphthalmia with retinitis pigmentosa and ocular anomalies, Nanophthalmos |
| MAB21L2 | 3 / 16 | Colobomatous microphthalmia, colobomatous microphthalmia-rhizomelic dysplasia syndrome, Microphthalmia |
| RARB | 3 / 16 | Anophthalmia, Microphthalmia, Microphthalmos |
| SHH | 3 / 16 | Colobomatous microphthalmia, Microphthalmia, Microphthalmos |
| TENM3 | 3 / 16 | Colobomatous microphthalmia, Microphthalmia, Microphthalmos |
| VAX1 | 3 / 16 | Anophthalmia/microphthalmia-esophageal atresia syndrome, Microphthalmia, Microphthalmos |
| ARHGAP35 | 2 / 16 | Anophthalmia, Microphthalmos |
| BMP4 | 2 / 16 | Anophthalmia/microphthalmia-esophageal atresia syndrome, Microphthalmia |
| ELP4 | 2 / 16 | Anophthalmia, Anophthalmia/microphthalmia-esophageal atresia syndrome |
| HCCS | 2 / 16 | Microphthalmia, Microphthalmos |
| HMGB3 | 2 / 16 | Microphthalmia, X-linked colobomatous microphthalmia, microcephaly, intellectual disability, short stature syndrome |
| HMX1 | 2 / 16 | Microphthalmia, Microphthalmos |
| MYO18B | 2 / 16 | Klippel-Feil anomaly-myopathy-facial dysmorphism syndrome, Klippel-feil syndrome |
| PITX3 | 2 / 16 | Anophthalmia/microphthalmia-esophageal atresia syndrome, Microphthalmos |
| SMOC1 | 2 / 16 | Anophthalmia, Microphthalmia |
| TFAP2A | 2 / 16 | Anophthalmia/microphthalmia-esophageal atresia syndrome, Microphthalmos |
| TMEM98 | 2 / 16 | Nanophthalmos, nanophthalmos 4 |
| WNT7B | 2 / 16 | Anophthalmia, Anophthalmia/microphthalmia-esophageal atresia syndrome |
| ZNF219 | 2 / 16 | Microphthalmia, Microphthalmos |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Basal cell carcinoma | KEGG | 5 / 63 | 12.5× | 4.69e-5 | 1.21e-3 ✓ sig. |
| TFAP2 (AP-2) family regulates transcription of other transcription factors | Reactome | 2 / 4 | 79.0× | 2.35e-4 | 4.44e-3 ✓ sig. |
| Signaling pathways regulating pluripotency of stem cells | KEGG | 6 / 144 | 6.6× | 2.94e-4 | 5.27e-3 ✓ sig. |
| Gastric cancer | KEGG | 6 / 150 | 6.3× | 3.66e-4 | 6.26e-3 ✓ sig. |
| Hippo signaling pathway | KEGG | 6 / 157 | 6.0× | 4.66e-4 | 7.55e-3 ✓ sig. |
| Ligand-receptor interactions | Reactome | 2 / 7 | 45.2× | 8.13e-4 | 1.16e-2 ✓ sig. |
| RNF mutants show enhanced WNT signaling and proliferation | Reactome | 2 / 8 | 39.5× | 1.08e-3 | 1.44e-2 ✓ sig. |
| Retinoid cycle disease events | Reactome | 2 / 13 | 24.3× | 2.95e-3 | 3.04e-2 ✓ sig. |
| Activation of SMO | Reactome | 2 / 18 | 17.6× | 5.66e-3 | 4.75e-2 ✓ sig. |
| Pathways in cancer | KEGG | 9 / 533 | 2.7× | 6.30e-3 | 5.10e-2 |
| Defective ABCB6 causes isolated colobomatous microphthalmia 7 (MCOPCB7) | Reactome | 1 / 1 | 158× | 6.33e-3 | 5.11e-2 |
| Retinoid metabolism disease events | Reactome | 1 / 1 | 158× | 6.33e-3 | 5.11e-2 |
| WNT ligand secretion is abrogated by the PORCN inhibitor LGK974 | Reactome | 1 / 1 | 158× | 6.33e-3 | 5.11e-2 |
| The canonical retinoid cycle in rods (twilight vision) | Reactome | 2 / 20 | 15.8× | 6.97e-3 | 5.45e-2 |
| Regulation of FZD by ubiquitination | Reactome | 2 / 21 | 15.1× | 7.68e-3 | 5.81e-2 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| camera-type eye development | GO:0043010 | 16 / 74 | 53.2× | 5.82e-24 | 1.63e-20 ✓ sig. |
| eye development | GO:0001654 | 9 / 49 | 45.2× | 3.36e-13 | 1.69e-10 ✓ sig. |
| visual perception | GO:0007601 | 13 / 215 | 14.9× | 3.47e-12 | 1.41e-9 ✓ sig. |
| lens development in camera-type eye | GO:0002088 | 8 / 48 | 41.0× | 1.70e-11 | 5.91e-9 ✓ sig. |
| pituitary gland development | GO:0021983 | 6 / 30 | 49.2× | 2.03e-9 | 4.19e-7 ✓ sig. |
| telencephalon regionalization | GO:0021978 | 4 / 7 | 141× | 8.76e-9 | 1.53e-6 ✓ sig. |
| forebrain development | GO:0030900 | 7 / 76 | 22.6× | 2.42e-8 | 3.68e-6 ✓ sig. |
| metanephric collecting duct development | GO:0072205 | 4 / 9 | 109× | 3.13e-8 | 4.55e-6 ✓ sig. |
| negative regulation of transcription by RNA polymerase II | GO:0000122 | 18 / 1,002 | 4.4× | 7.53e-8 | 9.49e-6 ✓ sig. |
| embryonic hindlimb morphogenesis | GO:0035116 | 5 / 29 | 42.4× | 1.07e-7 | 1.28e-5 ✓ sig. |
| positive regulation of transcription by RNA polymerase II | GO:0045944 | 19 / 1,208 | 3.9× | 2.43e-7 | 2.55e-5 ✓ sig. |
| lung development | GO:0030324 | 7 / 108 | 15.9× | 2.79e-7 | 2.87e-5 ✓ sig. |
| odontogenesis | GO:0042476 | 5 / 36 | 34.2× | 3.33e-7 | 3.32e-5 ✓ sig. |
| smooth muscle tissue development | GO:0048745 | 4 / 16 | 61.5× | 4.43e-7 | 4.22e-5 ✓ sig. |
| positive regulation of DNA-templated transcription | GO:0045893 | 15 / 778 | 4.7× | 4.54e-7 | 4.31e-5 ✓ sig. |